Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Sterling Biotech case:...

    Sterling Biotech case: Supplementary charge sheet filed

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-10-01T10:20:52+05:30  |  Updated On 1 Oct 2018 10:20 AM IST
    Sterling Biotech case: Supplementary charge sheet filed

    New Delhi: The Enforcement Directorate (ED) on Saturday filed a supplementary charge sheet against a man arrested for allegedly sending Rs 25 lakh to a politician, in connection with the Rs 5,000-crore Sterling Biotech bank fraud case.


    Delhi's Patiala House court, where the charge sheet was filed, is slated to consider the case for hearing on October 3.


    Earlier this week, India asked the Nigerian Interpol about the whereabouts of fugitive businessman and director of Sterling Biotech, Nitin Sandesara, who fled the country along with his family members.


    During ED's probe, it came to light that Sandesara's company alleged took loans of over Rs. 5,000 crores from a consortium of various banks led by Andhra Bank, which subsequently turned into bad loans or Non-Performing Assets (NPAs).


    Read Also: ED to File Charge Sheet Against Sterling Biotech in Bank Loan Fraud Case of Over Rs 5000 Crore


    The probe also disclosed that the promoters associated with the company built more than 300 shell and fake companies in India and abroad, including Nigeria, United Arab Emirates, British Virgin Islands, USA and Mauritius to divert and misuse loan funds. The Sandesara brothers reportedly controlled these fake companies through dummy detractors.

    Andhra BankBank fraud loanDelhi's Patiala House courtEDEnforcement DirectorateNitin SandesaraNon-Performing AssetsNPARs 5000 CroreSterling Biotech

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok